KDM5A inhibition is therefore a logical therapeutic concept for RB−/− OS, as its inhibition would restore mitochondrial function, allow for differentiation, and ultimately diminish tumor cell proliferation.90,91. This evidence concerns the gene KDM5A and neoplasm.